drugset / Trial / NCT02044419

A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled

NCT02044419

Phase 1 Completed 32 enrolled Aegerion Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelOther

Summary

To compare the relative bioavailability of lomitapide when administered by sprinkling the contents of a 20 mg capsule of lomitapide in applesauce or in mashed banana to a single oral intact capsule dose of 20 mg lomitapide in healthy subjects.

Timeline

Start
2013-10-30
Primary completion
2013-12-23
Completion
2013-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject lomitapide Small molecule 20 mg Oral

Indications

No indication recorded.